106 related articles for article (PubMed ID: 8757956)
1. An anti-CD2 mAb induces immunosuppression and hyporesponsiveness of CD2+ human T cells in vitro.
Latinne D; De La Parra B; Nizet Y; Cornet A; Giovino-Barry V; Monroy RL; White-Scharf ME; Bazin H
Int Immunol; 1996 Jul; 8(7):1113-9. PubMed ID: 8757956
[TBL] [Abstract][Full Text] [Related]
2. The experimental (in vitro) and clinical (in vivo) immunosuppressive effects of a rat IgG2b anti-human CD2 mAb, LO-CD2a/BTI-322.
Nizet Y; Chentoufi AA; de la Parra B; Lewalle P; Rouas R; Cornet A; Besse T; Mourad M; Malaise J; Squifflet JP; Bazin H; Latinne D
Transplantation; 2000 Apr; 69(7):1420-8. PubMed ID: 10798765
[TBL] [Abstract][Full Text] [Related]
3. Effects on human and nonhuman primate immune response of a new rat anti-CD2 monoclonal antibody.
Dehoux JP; Talpe S; Dewolf N; Otsuka M; Oike F; Jamar F; de la Parra B; Latinne D; Bazin H; Gianello P
Transplantation; 2000 Jun; 69(12):2622-33. PubMed ID: 10910286
[TBL] [Abstract][Full Text] [Related]
4. Modulation of antigen-specific T cell response by a non-mitogenic anti-CD3 antibody.
Li J; Davis J; Bracht M; Carton J; Armstrong J; Gao W; Scallon B; Fung R; Emmell E; Zimmerman M; Griswold DE; Li L
Int Immunopharmacol; 2006 Jun; 6(6):880-91. PubMed ID: 16644473
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporine preserves the anergic state of human T cells induced by costimulation blockade in vitro.
Koenen HJ; Fasse E; Joosten I
Transplantation; 2005 Aug; 80(4):522-9. PubMed ID: 16123728
[TBL] [Abstract][Full Text] [Related]
6. Effect in vitro and in vivo of a rat anti-CD2 monoclonal antibody (LO-CD2b) on pig-to-baboon xenogeneic cellular (T and natural killer cells) immune response.
Dehoux JP; de la Parra B; Latinne D; Bazin H; Gianello P
Xenotransplantation; 2001 Aug; 8(3):193-201. PubMed ID: 11472627
[TBL] [Abstract][Full Text] [Related]
7. CD2 regulates responsiveness of activated T cells to interleukin 12.
Gollob JA; Li J; Reinherz EL; Ritz J
J Exp Med; 1995 Sep; 182(3):721-31. PubMed ID: 7544396
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis of human naive NK cells mediated by a rat IgG2b anti CD2 mAb through a fractricidal ADCC reaction.
Nizet Y; Chentoufi AA; Havaux X; Kinet I; Cormont F; Bazin H; Latinne D
Immunol Lett; 1999 Jun; 68(2-3):229-35. PubMed ID: 10424425
[TBL] [Abstract][Full Text] [Related]
9. Anti-CD3 antibodies OKT3 and hOKT3gamma1(Ala-Ala) induce proliferation of T cells but impair expansion of alloreactive T cells; aspecifc T cell proliferation induced by anti-CD3 antibodies correlates with impaired expansion of alloreactive T cells.
Popma SH; Griswold DE; Li L
Int Immunopharmacol; 2005 Jan; 5(1):155-62. PubMed ID: 15589476
[TBL] [Abstract][Full Text] [Related]
10. Increased cAMP and cAMP-dependent protein kinase activity mediate anti-CD2 induced suppression of anti-CD3-driven interleukin-2 production and CD25 expression.
Lin J; Gettys TW; Qin L; Chavin KD; Yang Q; Ding Y; Punch JD; Bromberg JS
Pathobiology; 1995; 63(4):175-87. PubMed ID: 8866788
[TBL] [Abstract][Full Text] [Related]
11. Selective deletion of antigen-specific, activated T cells by a humanized MAB to CD2 (MEDI-507) is mediated by NK cells.
Branco L; Barren P; Mao SY; Pfarr D; Kaplan R; Postema C; Langermann S; Koenig S; Johnson S
Transplantation; 1999 Nov; 68(10):1588-96. PubMed ID: 10589960
[TBL] [Abstract][Full Text] [Related]
12. Targeting additional costimulatory pathways: a subtle role for CD2.
Dumont C; Deas O; Hebib C; Durrbach A; Hirsch F; Charpentier B; Senik A
Transplant Proc; 2001; 33(1-2):199-200. PubMed ID: 11266778
[No Abstract] [Full Text] [Related]
13. HuM291, a humanized anti-CD3 antibody, is immunosuppressive to T cells while exhibiting reduced mitogenicity in vitro.
Cole MS; Stellrecht KE; Shi JD; Homola M; Hsu DH; Anasetti C; Vasquez M; Tso JY
Transplantation; 1999 Aug; 68(4):563-71. PubMed ID: 10480417
[TBL] [Abstract][Full Text] [Related]
14. Co-stimulation via CD28 induces activation of a refractory subset of MRL-lpr/lpr T lymphocytes.
Clements JL; Winslow G; Donahue C; Cooper SM; Allison JP; Budd RC
Int Immunol; 1993 Nov; 5(11):1451-60. PubMed ID: 7903158
[TBL] [Abstract][Full Text] [Related]
15. Mitogenic properties of a bispecific single-chain Fv-Ig fusion generated from CD2-specific mAb to distinct epitopes.
Connelly RJ; Hayden MS; Scholler JK; Tsu TT; Dupont B; Ledbetter JA; Kanner SB
Int Immunol; 1998 Dec; 10(12):1863-72. PubMed ID: 9885907
[TBL] [Abstract][Full Text] [Related]
16. Combined anti-CD2 and anti-CD3 receptor monoclonal antibodies induce donor-specific tolerance in a cardiac transplant model.
Chavin KD; Qin L; Lin J; Yagita H; Bromberg JS
J Immunol; 1993 Dec; 151(12):7249-59. PubMed ID: 7903105
[TBL] [Abstract][Full Text] [Related]
17. T lymphocyte activation through the C28 pathway is insensitive to inhibition by the immunosuppressive drug FK-506.
Kay JE; Benzie CR
Immunol Lett; 1989 Dec; 23(2):155-9. PubMed ID: 2483716
[TBL] [Abstract][Full Text] [Related]
18. Potent apoptotic signaling and subsequent unresponsiveness induced by a single CD2 mAb (BTI-322) in activated human peripheral T cells.
Dumont C; Déas O; Mollereau B; Hebib C; Giovino-Barry V; Bernard A; Hirsch F; Charpentier B; Senik A
J Immunol; 1998 Apr; 160(8):3797-804. PubMed ID: 9558083
[TBL] [Abstract][Full Text] [Related]
19. CD3 and CD2 ligation alters CD49d epitope expression.
Lin J; Qin L; Chavin KD; Ding Y; Punch JD; Yang Q; Burkly LC; Bromberg JS
Pathobiology; 1995; 63(3):119-32. PubMed ID: 8821628
[TBL] [Abstract][Full Text] [Related]
20. Differential immunosuppressive activity of monoclonal CD2 antibodies on allograft rejection versus specific antibody production.
Sido B; Dengler TJ; Otto G; Zimmermann R; Müller P; Meuer SC
Eur J Immunol; 1998 Apr; 28(4):1347-57. PubMed ID: 9565375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
